PROBUPHINE INSERTION & REMOVAL TRAINING
This announcement has 1 attachment:
PROBUPHINE INSERTION & REMOVAL TRAINING - NON-CE Event
Thursday, March 30 10:00-2:00pm
~ Stoweflake Mountain Resort ~ Stowe, VT ~
PROBUPHINE (buprenorphine implant), is a long acting implant (6 month duration of treatment) for the maintenance treatment of opioid dependence in patients who have achieved and sustained prolonged clinical stability on low-to-moderate doses of a transmucosal buprenorphine-containing products.
This skills-based clinical training is being presented by Braeburn Pharmaceuticals, the manufacturer of PROBUPHINE. It is offered for licensed advanced practice clinicians and physicians only. All Healthcare Providers performing insertions and/or removals of PROBUPHINE must successfully complete a live training program, and demonstrate procedural competency prior to inserting or removing the implants. PROBUPHINE will only be distributed to certified prescribers through a restricted distribution program.
Attendance is limited. There is no fee for this workshop, however pre-registration is required. Attendees must attend the full training and pass a competency exam in order to be included in the database of trained clinicians and approved to order the product.
No spouses or guests are permitted to attend any part of the training.
**Please note that you will not be compensated to attend this training. You will need to travel to the closest regional location for training. Basic travel expenses may be reimbursed if Braeburn guidelines are followed. More details supplied on the registration link above.**
To register for the non-CE event, click here.
Please see full prescribing information, including boxed warning, for Probuphine, click here.
Disclaimer: This non-CE event is ineligible to receive continuing registration credit and is not considered part of the VNPA’s accredited educational activity: 2017 Annual Conference. Promotion of a commercial product or service outside the commercial session’s meeting room or exhibit area is prohibited.
For more inforrmation, contact Julie Basol, JNB Marketing:
802 598 7424 JNB@gmav.net